Learn more about our work and how we help accelerate the global health response.
Explore how our investments are shaping disease responses.
Learn more
Financial grants to accelerate innovation in global health.
Learn more about the difference our work makes in the lives of people in low- and middle-income countries.
External evaluations provide independent assessments of our work.
Explore the technologies and interventions we're working on.
See where our work is being mentioned in the media world.
Resources for journalists and media representatives.
Unitaid welcomes U.S. FDA approval of lenacapavir and calls for urgent action on affordability and access
Unitaid accelerates push to eliminate cervical cancer by 2030 with US$50 million commitment over two years to improve access to screening and treatment
Africa’s Shift From Aid Dependency
Executive board affirms Unitaid’s vision for a changing global health landscape
The last mile in child medicine: The best HIV medicines for the youngest babies
Kenya pioneers a new tool in the fight against malaria
From principle to practice: Involving communities in research design for effective hepatitis C prevention
Unitaid’s Early Market Access Vehicle – an innovative demand-driven model to catalyze introduction of new optimal health products in low- and middle-income countries
From promise to impact: Unlocking lenacapavir’s potential to end HIV
The right health products for women and newborns, where and when they need them
Spotlighting women’s health at the World Economic Forum
Sally’s story: One woman’s fight against cervical cancer
